Date published: 2026-5-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

KOR-3 Activators

KOR-3 Activators, also known as κ-opioid receptor type 3 activators, are a class of chemical compounds that specifically bind to and modulate the activity of the κ-opioid receptor (KOR). KOR is one of the three main types of opioid receptors, the others being the μ-opioid receptor (MOR) and δ-opioid receptor (DOR). Unlike traditional agonists, which fully activate the receptor, activators in this context can have varying effects depending on their binding affinity, efficacy, and intrinsic activity at the receptor site. KOR-3 activators are particularly interesting because they can induce unique conformational changes in the receptor, leading to a distinct signaling cascade compared to other KOR ligands. This receptor is predominantly expressed in the central nervous system but also has peripheral distribution, influencing various physiological processes including mood regulation, stress response, and perception.The molecular mechanisms by which KOR-3 activators exert their effects involve the modulation of G-protein signaling pathways, particularly the Gαi/o proteins, which inhibit adenylate cyclase activity, thus reducing cyclic AMP (cAMP) levels within the cell. Additionally, these activators can influence other intracellular signaling cascades, such as the mitogen-activated protein kinase (MAPK) pathways, which are involved in cell differentiation, proliferation, and survival. The binding of KOR-3 activators often results in receptor internalization, desensitization, or downregulation, which are critical factors in the regulation of receptor sensitivity and responsiveness. Moreover, the distinct pharmacological profile of KOR-3 activators, characterized by their selectivity and specificity, makes them valuable tools for understanding the complex signaling networks associated with the κ-opioid receptor and their broader implications in cellular physiology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

NNC 63-0532

250685-44-0sc-203648
sc-203648A
10 mg
50 mg
$306.00
$1326.00
(0)

NNC 63-0532 functions as a KOR-3 ligand, characterized by its selective binding dynamics and unique conformational flexibility. The compound's ability to engage in hydrogen bonding and hydrophobic interactions enhances its affinity for target receptors. Its distinct electronic structure allows for modulation of electron density, influencing reaction kinetics. Furthermore, NNC 63-0532's solvation properties contribute to its stability in various environments, affecting its overall reactivity profile.

SCH 221510

322473-89-2sc-358790
sc-358790A
10 mg
50 mg
$363.00
$1566.00
(0)

SCH 221510 acts as a KOR-3 ligand, distinguished by its robust steric hindrance and specific electrostatic interactions that facilitate selective receptor engagement. The compound exhibits unique conformational adaptability, allowing it to navigate complex binding sites effectively. Its reactivity is influenced by the presence of electron-withdrawing groups, which enhance its electrophilic character. Additionally, SCH 221510's solubility characteristics play a crucial role in its interaction dynamics, impacting its overall behavior in diverse chemical environments.

MCOPPB trihydrochloride

1028969-49-4 (free base)sc-361249
sc-361249A
5 mg
25 mg
$96.00
$386.00
(0)

MCOPPB trihydrochloride functions as a KOR-3 ligand, characterized by its unique ability to form stable hydrogen bonds with receptor sites, enhancing binding affinity. Its structural rigidity promotes specific conformational states that optimize interaction with target proteins. The compound's high polarity and ionic nature contribute to its solubility in aqueous environments, facilitating rapid diffusion and effective receptor modulation. Additionally, its reaction kinetics are influenced by the presence of halide ions, which can alter its reactivity profile.

(±)-J 113397

217461-40-0sc-204020
sc-204020A
10 mg
50 mg
$249.00
$1060.00
(0)

J-113397 is a selective antagonist of the NOP receptor, which may indirectly affect receptor activity through receptor upregulation or changes in receptor dynamics.